UBC tissues; matched non-malignant tissues
svhuc1; 5637; RT-112; RT112; BIU-87; BIU87
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes)
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Nuclear-Cytoplasmic Fractionation; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; Transwell Assay; In Vivo Animal Model; H&E Staining; Clinical Sample Validation
-
circCA12 is up-regulated in bladder cancer tissues and cell lines and promotes malignant phenotypes including proliferation, invasion/migration, and metastasis. Mechanistically, circCA12 mainly localizes to the cytoplasm and functions as a ceRNA by sponging miR-1184, leading to upregulation of RAS family targets (KRAS/NRAS/HRAS) and promoting UBC progression.
0.7979
CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer.
combined biological and clinical study